Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 2:17 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 433–456 of 971 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Control (standard practice) Clear all

Conditions: Stroke Hemorrhagic
Interventions: Surgical management, Medical Management; Procedure · Other
Lead sponsor: Emory University; Other
Eligibility: 18 Years to 70 Years
Enrollment: 600 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2030
U.S. locations: 24
States / cities: Birmingham, Alabama • Little Rock, Arkansas • Palo Alto, California + 19 more

Conditions: Parkinson Disease
Interventions: MultiContext for PD Strategy Training, Standard of Care; Behavioral
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 40 Years and older
Enrollment: 57 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Knee Arthroplasty, Total, Analgesia, Opioid Use, Unspecified
Interventions: Shared Decision Making; Other
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years and older
Enrollment: 142 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 2
States / cities: Chicago, Illinois • Boston, Massachusetts

Conditions: Chemotherapy-induced Peripheral Neuropathy
Interventions: Symptom Care at Home with NP follow up; Other
Lead sponsor: University of Vermont; Other
Eligibility: 18 Years and older
Enrollment: 422 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 3
States / cities: Salt Lake City, Utah • Burlington, Vermont • Richmond, Virginia

Conditions: Cardiac Arrest
Interventions: ICU-RESUS CPR Improvement Bundle; Other
Lead sponsor: Children's Hospital of Philadelphia; Other
Eligibility: 37 Weeks to 18 Years
Enrollment: 1,127 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2021
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Functional Recovery, Upper Extremity Vascularized Composite Allotransplantation
Interventions: Upper Extremity Vascularized Composite Allotransplantation (VCA); Procedure
Lead sponsor: Yale University; Other
Eligibility: 18 Years and older
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2037
U.S. locations: 9
States / cities: Los Angeles, California • New Haven, Connecticut • Louisville, Kentucky + 6 more

Conditions: Colorectal Cancer
Interventions: interactive group education, navigation services and engagement of health care providers for referrals, and linkage to care., Education Session on General Health; Behavioral
Lead sponsor: Temple University; Other
Eligibility: 50 Years to 85 Years
Enrollment: 925 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2015
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Liver Transplant Recipient
Interventions: Tacrolimus (reduced tacrolimus), Everolimus (reduced tacrolimus), Tacrolimus (tacrolimus elimination), Everolimus (tacrolimus elimination), Tacrolimus (tacrolimus control), Corticosteroids; Drug
Lead sponsor: Novartis Pharmaceuticals; Industry
Eligibility: 20 Years to 75 Years
Enrollment: 284 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2013
U.S. locations: 15
States / cities: Washington D.C., District of Columbia • Tampa, Florida • Lexington, Kentucky + 10 more

Conditions: Heart Failure
Interventions: Palliative Care Consultation, Control; Other
Lead sponsor: Allina Health System; Other
Eligibility: 18 Years and older
Enrollment: 232 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Smoking, Smoking Cessation
Interventions: TAMI Coach; Behavioral
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 440 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 2
States / cities: San Francisco, California

Conditions: Enhanced Recovery Pathway, Endoscopy
Interventions: Ondansetron 4 MG, Lactated Ringers, Intravenous, Early Mobilization, Early PO Intake; Drug · Other
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years and older
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Memory Disorders, Mild Cognitive Impairment, Alzheimer's Disease
Interventions: Intervention Group, Control Group; Behavioral
Lead sponsor: Boston University; Other
Eligibility: 50 Years to 90 Years · Female only
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2020
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Needle Phobia
Interventions: Lidocaine patch 4%, Placebo Patch, 1% Lidocaine Skin Wheal; Drug · Other
Lead sponsor: Ohio State University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 66 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Healthcare-Associated Pneumonia
Interventions: Oral Hygiene - teeth brushing; Other
Lead sponsor: Orlando Health, Inc.; Other
Eligibility: 18 Years and older
Enrollment: 8,709 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Orlando, Florida

Conditions: Meditation, Spine Surgery, Pain, Postoperative
Interventions: Mindfulness meditation; Behavioral
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 18 Years to 80 Years
Enrollment: 38 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2020
U.S. locations: 1
States / cities: New York, New York

Conditions: Cognitive Impairment
Interventions: Self-Administered Gerocognitive Examination (SAGE) or Electronic Self-Administered Gerocognitive Examination (eSAGE), Informant Conversation; Other
Lead sponsor: Ohio State University; Other
Eligibility: 65 Years to 89 Years
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Inflammatory Bowel Disease
Interventions: Filgotinib, Placebo, Standard of Care; Drug
Lead sponsor: Lakefront Biotherapeutics NV; Industry
Eligibility: 21 Years to 65 Years · Male only
Enrollment: 139 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2023
U.S. locations: 10
States / cities: San Diego, California • Lakewood Rch, Florida • Miami, Florida + 7 more

Conditions: Anemia, Iron-Deficiency
Interventions: Iron sucrose, Epoetin Alfa, Blood Transfusion; Drug · Other
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 19 Years to 80 Years
Enrollment: 51 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Obesity
Interventions: Intervention Group, Control Group; Behavioral
Lead sponsor: BETH COMERFORD; Other
Eligibility: Not listed
Enrollment: 58 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Derby, Connecticut

Conditions: Mitral Regurgitation, Mitral Valve Regurgitation, Treatment of Functional Mitral Regurgitation in Symptomatic Heart Failure Subjects, Heart Failure
Interventions: MitraClip System; Device
Lead sponsor: Abbott Medical Devices; Industry
Eligibility: 18 Years and older
Enrollment: 776 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2024
U.S. locations: 81
States / cities: Birmingham, Alabama • Phoenix, Arizona • Scottsdale, Arizona + 65 more

Conditions: Metastatic Breast Cancer, Leptomeningeal Disease
Interventions: High-dose Methotrexate (8 gm/m2; HD-MTX); Drug
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years and older
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2027
U.S. locations: 3
States / cities: Baltimore, Maryland • St Louis, Missouri • Winston-Salem, North Carolina

Conditions: Chronic Pain and Relapse Prevention
Interventions: Chronic pain therapeutic interactive voice response (TIVR) system; Behavioral
Lead sponsor: University of Vermont; Other
Eligibility: 18 Years and older
Enrollment: 158 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2012
U.S. locations: 1
States / cities: Burlington, Vermont

Conditions: Hiv, Sexually Transmitted Diseases, Economic Problems
Interventions: Empowered to Test Yourself, Educational Control; Behavioral · Other
Lead sponsor: Johns Hopkins Bloomberg School of Public Health; Other
Eligibility: 15 Years to 59 Years · Female only
Enrollment: 31 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2025
U.S. locations: 4
States / cities: Austin, Texas • Dallas, Texas • Houston, Texas + 1 more

Conditions: Chronic Disease, Drug Drug Interaction, Medication Adherence
Interventions: Educational Materials for Chronic Disease Management Test (CDMT); Other
Lead sponsor: Qure Healthcare, LLC; Industry
Eligibility: Not listed
Enrollment: 166 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: San Francisco, California

Search by objective public record fields.

Rapid Evacuation and Access of Cerebral Hemorrhage Trial

Feasibility and Effect of a Strategy-Based Cognitive Intervention for Parkinson Disease

Shared Decision Aid for Post-Total Knee Arthroplasty Opioid Prescribing

Remote Monitoring and Management of Chemotherapy Induced Peripheral Neuropathy

The ICU-Resuscitation Project (ICU-RESUS)

Upper Extremity Vascularized Composite Allotransplantation: A Study Evaluating Safety, Functional Outcomes, and Patient-Reported Psychosocial Outcomes

Korean CRC Screening Study PT13599

Extension Study to Evaluate the Long-term Efficacy and Safety of Everolimus in Liver Transplant Recipients

Palliative Care for Heart Failure Patients

Technology Assisted Motivational Interviewing

Enhanced Recovery Pathway for Endoscopy

Effectiveness of Home-based Electronic Cognitive Therapy in Alzheimer's Disease

Lidocaine Patch for Epidural Placement Pain in Laboring Women

Hospital-acquired Pneumonia Prevention: Intervention, Evaluation & Research

Mindfulness Meditation for Spine Surgery Pain

SAGE for the Early Detection of Cognitive Impairment at Primary Care Provider Visits

Study to Evaluate the Testicular Safety of Filgotinib in Adult Males With Moderately to Severely Active Inflammatory Bowel Disease

The Benefits of a Preoperative Anemia Management Program

Fruit and Vegetable Prescription Program

Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients With Functional Mitral Regurgitation (The COAPT Trial) and COAPT CAS

Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis

A Telephone Feedback System for Prevention of Chronic Pain Relapse

Increasing HIV/STI Home Testing Via a Digital Intervention Among Black Women

Clinical Utility of CDMT Among VillageMD Providers